MedXCell
Business Services · Switzerland · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Avenue Des Planches 20c, Montreux, Vaud,...Website
www.medxcell.chRevenue
<$5 MillionIndustry
About MedXCell
Is MedXCell your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on MedXCell recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check out if MedXCell is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when MedXCell launches new products
Click to see if MedXCell had a recent Job posting/layoffs
Check if MedXCell has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once MedXCell has new funding data
MedXCell, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at MedXCell
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
MedXCell is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
MedXCell is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about MedXCell.
MedXCell Tech Stack
A closer look at the technologies used by MedXCell
MedXCell News & Media
Montpellier. The university takes a stake in MedXCell Science
Across Jill Martin Posted in 24 April 21 at 19:35 Professor Christian Jorgensen, Director of IRBM, and Dr Daniel Noel, of INSERM, confirm that MedXCell
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding MedXCell
MedXCell is a Swiss biotech venture builder that collaborates with academic institutions to co-design early-stage projects, transforming scientific breakthroughs into clinical assets. The company focuses on developing self-standing ventures in major disease areas such as cancer and autoimmune disorders, with a portfolio that includes CYTEA BIO and... Read More